Melanoma therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2303992

Methods for treating treatment-naive as well as treatment-experienced patients having melanoma to increase the progression-free survival time involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g., preferably pegylated interferon alfa-2b, as adjuvant therapy to definitive surgery are disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Melanoma therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanoma therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanoma therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2060959

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.